New drug aims to shield kidneys during risky heart operations
Disease control
Completed
This study tested whether a drug called ilofotase alfa could prevent or reduce kidney damage in patients undergoing major open heart surgery. It involved 271 adults with pre-existing reduced kidney function who were at high risk for further injury. Patients received either the st…
Phase: PHASE2 • Sponsor: AM-Pharma • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC